Case number 2017-2377
Cephalon Inc. v. InnoPharma Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 25, 2019 | 73 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [72] filed by Appellants Hospira, Inc., InnoPharma Inc. and Cross-Appellant Cephalon Inc.; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [580952] [17-2377, 17-2378] [JAB] [Entered: 01/25/2019 12:20 PM] (2) |
| Jan 24, 2019 | 72 | MOTION of Cross-Appellant Cephalon Inc. and Appellants Hospira, Inc. and InnoPharma Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 01/24/2019 by email. [580683] [17-2377] [Sara Horton] [Entered: 01/24/2019 03:30 PM] (9) |
| Jan 15, 2019 | 71 | Response to notice of oral argument from the Cross-Appellant Cephalon Inc.. [578211] [17-2377] [William Jay] [Entered: 01/15/2019 04:04 PM] (3) |
| Jan 15, 2019 | 70 | Response to notice of oral argument from the Appellants InnoPharma Inc. and Hospira, Inc.. [578056] [17-2377] [Bradford Lyerla] [Entered: 01/15/2019 11:02 AM] (3) |
| Dec 17, 2018 | 69 | NOTICE OF ORAL ARGUMENT. Panel: 1902J. Case scheduled Feb 07, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 01/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [572270] [JAB] [Entered: 12/17/2018 03:29 PM] (2) |
| Jul 20, 2018 | 68 | Notice from Appellants Hospira, Inc. and InnoPharma Inc. regarding conflicts with oral argument (November 5-9, 2018). Service: 07/20/2018 by email. [537213] [17-2377] [Bradford Lyerla] [Entered: 07/20/2018 10:57 AM] (2) |
| Jul 17, 2018 | 66 | 6 paper copies of the Corrected Joint Appendix Brief (Vol. I - III) [63] received from Appellants Hospira, Inc. and InnoPharma Inc.. [536512] [CJF] [Entered: 07/17/2018 01:00 PM] (0) |
| Jul 13, 2018 | 65 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [SEP, OCT, NOV], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 07/20/2018. [535630] [MJL] [Entered: 07/13/2018 09:30 AM] (0) |
| Jul 13, 2018 | 64 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The cover of the joint appendix [62] does not comply with FCR 30(a)(6). CORRECTION: For multi-volume appendices, the volume number must appear in roman numerals and at the top of each cover page. Please ensure future appendices comply with FCR 30(a)(6). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [535624] [MJL] [Entered: 07/13/2018 09:23 AM] (0) |
| Jul 9, 2018 | 63 | CORRECTED APPENDIX FILED for Hospira, Inc. and InnoPharma Inc. [62]. Number of Pages: 1387. Service: 07/09/2018 by email. The paper copies of the appendix should be received by the court on or before 07/20/2018. [535621] [MJL] [Entered: 07/13/2018 09:20 AM] (1387) |
| Jul 9, 2018 | 62 | TENDERED from Appellants Hospira, Inc. and InnoPharma Inc.. Title: CORRECTED JOINT APPENDIX. Service: 07/09/2018 by email. [534645] [17-2377] [Bradford Lyerla] [Entered: 07/09/2018 07:16 PM] (1387) |
| Jul 9, 2018 | 61 | Notice of Correction to the Brief Doc No. [56] for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 07/09/2018 by email. [534643] [17-2377] [Bradford Lyerla] [Entered: 07/09/2018 07:13 PM] (4) |
| Jul 9, 2018 | 60 | Notice from Cross-Appellant Cephalon Inc. regarding conflicts with oral argument (September 4-6, December 3-7). Service: 07/09/2018 by email. [534611] [17-2377] [William Jay] [Entered: 07/09/2018 05:26 PM] (2) |
| Jul 2, 2018 | 67 | 6 CD copies of the Opening Brief [27], Reply Brief [48] and Joint Appendix received from Appellants Hospira, Inc. and InnoPharma Inc.. [536515] [CJF] [Entered: 07/17/2018 01:09 PM] (0) |
| Jul 2, 2018 | 59 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 07/02/2018 by email. [533263] [17-2377] [Bradford Lyerla] [Entered: 07/02/2018 08:48 PM] (4) |
| Jul 2, 2018 | 58 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants InnoPharma Inc. and Hospira, Inc.. Service: 07/02/2018 by email. [533262] [17-2377] [Bradford Lyerla] [Entered: 07/02/2018 08:46 PM] (3) |
| Jul 2, 2018 | 57 | Notice of intent to file corresponding briefs on CD-ROM for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 07/02/2018 by email. [533261] [17-2377] [Bradford Lyerla] [Entered: 07/02/2018 08:36 PM] (4) |
| Jul 2, 2018 | 56 | TENDERED from Appellants InnoPharma Inc. and Hospira, Inc.. Title: JOINT APPENDIX. Service: 07/02/2018 by email. [533260] [17-2377]. This appendix has been corrected. See Doc. No. [63]. [Bradford Lyerla] [Entered: 07/02/2018 08:26 PM] (0) |
| Jul 2, 2018 | 55 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Cross-Appellant Cephalon Inc.. Service: 07/02/2018 by email. [533233] [17-2377] [William Jay] [Entered: 07/02/2018 05:18 PM] (3) |
| Jun 26, 2018 | 54 | 6 paper copies of the Reply Brief [53] received from Cross-Appellant Cephalon Inc.. [532094] [CJF] [Entered: 06/26/2018 04:26 PM] (0) |
| Jun 25, 2018 | 53 | REPLY BRIEF FILED for Cross-Appellant Cephalon Inc. [52]. Number of Pages: 17. Service: 06/25/2018 by email. The paper copies of the brief should be received by the court on or before 07/03/2018. Appendix is due 07/02/2018. [532016] [MJL] [Entered: 06/26/2018 02:08 PM] (26) |
| Jun 25, 2018 | 52 | TENDERED from Cross-Appellant Cephalon Inc.. Title: REPLY BRIEF. Service: 06/25/2018 by email. [531782] [17-2377] [William Jay] [Entered: 06/25/2018 04:01 PM] (26) |
| May 15, 2018 | 51 | **TEXT ONLY** ORDER granting motion to extend the time to file cross-appellant's reply brief [49] filed by Cross-Appellant Cephalon Inc. The brief is due 06/25/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [521797]--[Edited 05/29/2018 by MJL to correct brief type]. [MJL] [Entered: 05/15/2018 02:29 PM] (0) |
| May 15, 2018 | 49 | MOTION of Cross-Appellant Cephalon Inc. to extend the time to 06/25/2018 to file the Cross-Appellant's Reply Brief. [Consent: unopposed]. Service: 05/15/2018 by email. [521652] [17-2377] [William Jay] [Entered: 05/15/2018 10:28 AM] (9) |
| May 14, 2018 | 50 | 6 paper copies of the Reply Brief [48] received from Appellants Hospira, Inc. and InnoPharma Inc.. [521692] [CJF] [Entered: 05/15/2018 11:15 AM] (0) |
| May 10, 2018 | 48 | REPLY BRIEF FILED for Appellants Hospira, Inc. and InnoPharma Inc. [47]. Number of Pages: 43. Service: 05/10/2018 by email. The paper copies of the brief should be received by the court on or before 05/18/2018. Cross-Appellant's reply brief is due 05/24/2018. [520915] [MJL] [Entered: 05/11/2018 09:20 AM] (53) |
| May 10, 2018 | 47 | TENDERED from Appellants Hospira, Inc. and InnoPharma Inc.. Title: REPLY BRIEF. Service: 05/10/2018 by email. [520865] [17-2377] [Bradford Lyerla] [Entered: 05/10/2018 05:54 PM] (53) |
| Feb 28, 2018 | 46 | ORDER filed. The motion [45] is granted. The revised official caption is reflected in this order. Service: 02/28/2018 by clerk. [501854] [17-2377, 17-2378] [LMS] [Entered: 02/28/2018 03:56 PM] (2) |
| Feb 23, 2018 | 45 | Objection to the official caption pursuant to Rule 12 Practice Note by Not Parties Apotex Corp. and Apotex Inc.. Service: 02/23/2018 by email. [500849] [Steven Feldman] [Entered: 02/23/2018 04:57 PM] (7) |
| Feb 21, 2018 | 44 | REMINDER: All counsel of record are reminded of their responsibility per FCR 47.3(c)(1) and 47.4(c) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. The court notes that the COI attached to Apellants' motion [42] contains updated information in item #5. Please submit an amended COI promptly. [499867] [MJL] [Entered: 02/21/2018 03:11 PM] (0) |
| Feb 21, 2018 | 43 | **TEXT ONLY** ORDER granting motion to extend time to file appellants' response and reply brief [42] filed by Appellants Hospira, Inc. and InnoPharma Inc. The brief is due 05/10/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [499865] [MJL] [Entered: 02/21/2018 03:08 PM] (0) |
| Feb 21, 2018 | 42 | MOTION of Appellants Hospira, Inc. and InnoPharma Inc. to extend the time to 05/10/2018 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/21/2018 by email. [499850] [Bradford Lyerla] [Entered: 02/21/2018 02:55 PM] (10) |
| Feb 21, 2018 | 41 | Entry of appearance for Adam G. Unikowsky as of counsel for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 02/21/2018 by email. [499809] [Adam Unikowsky] [Entered: 02/21/2018 02:09 PM] (2) |
| Feb 20, 2018 | 40 | 6 paper copies of the Corrected Opening Response Brief [39] received from Cross-Appellant Cephalon Inc. [499575] [JCP] [Entered: 02/21/2018 08:09 AM] (0) |
| Feb 13, 2018 | 37 | Corrected Certificate of Interest for the Cross-Appellant Cephalon Inc.. Service: 02/13/2018 by email. [497477] [William Jay] [Entered: 02/13/2018 05:12 PM] (3) |
| Feb 13, 2018 | 36 | NOTICE OF REJECTION: The Principal and Response Brief for Cross-Appellant Cephalon Inc. [35] is not in compliance with the rules of this court and is therefore rejected for filing. Corrected brief due 02/27/2018. Appellants' response and reply brief is due 03/26/2018. Service as of this date by Clerk of Court. [497250] [MJL] [Entered: 02/13/2018 08:49 AM] (2) |
| Feb 13, 2018 | 38 | TENDERED from Cross-Appellant Cephalon Inc.. Title: CORRECTED RESPONSE BRIEF. Service: 02/13/2018 by email. [497478] [William Jay] [Entered: 02/13/2018 05:15 PM] (90) |
| Feb 13, 2018 | 39 | CORRECTED BRIEF FILED for Cross-Appellant Cephalon Inc. [38]. Number of Pages: 76. Service: 02/13/2018 by email. The paper copies of the brief should be received by the court on or before 02/23/2018. [497936] [MJL] [Entered: 02/15/2018 09:00 AM] (90) |
| Feb 12, 2018 | 35 | TENDERED from Cross-Appellant Cephalon Inc.. Title: RESPONSE BRIEF. Service: 02/12/2018 by email. [497158]. This brief has been rejected. See Doc. No. [36]. [William Jay] [Entered: 02/12/2018 05:21 PM] (0) |
| Jan 2, 2018 | 34 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Appellants' motion [32] did not include a certificate of compliance. CORRECTION: Pursuant to FRAP 32(g)(1), motions must contain a certificate of compliance with the word count. Please ensure future motions include the certificate of compliance. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [486550] [MJL] [Entered: 01/02/2018 11:10 AM] (0) |
| Jan 2, 2018 | 33 | **TEXT ONLY** ORDER granting motion to withdraw attorney [32] filed by Appellants Hospira, Inc. and InnoPharma Inc. Joshua M. Segal is withdrawn as counsel for Appellants. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [486549] [MJL] [Entered: 01/02/2018 11:08 AM] (0) |
| Dec 28, 2017 | 32 | MOTION of Appellants Hospira, Inc. and InnoPharma Inc. to withdraw counsel Joshua M. Segal. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/28/2017 by email. [486197] [Bradford Lyerla] [Entered: 12/28/2017 11:21 PM] (6) |
| Nov 15, 2017 | 31 | **TEXT ONLY** ORDER granting motion to extend time to file cross-appellant's opening and response brief [30] filed by Cross-Appellant Cephalon Inc. The brief is due 02/12/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [475570] [MJL] [Entered: 11/15/2017 08:17 AM] (0) |
| Nov 14, 2017 | 30 | MOTION of Cross-Appellant Cephalon Inc. to extend the time to 02/12/2018 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 11/14/2017 by email. [475543] [William Jay] [Entered: 11/14/2017 07:39 PM] (9) |
| Nov 7, 2017 | 29 | 6 paper copies of the Opening Brief [27] received from Appellants Hospira, Inc. and InnoPharma Inc. [473825] [CW] [Entered: 11/07/2017 03:44 PM] (0) |
| Nov 3, 2017 | 28 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Some appendix references in Appellants' brief [26] did not follow the format specified by FCR 30(b)(4)(E). Specifically, abbreviated page ranges are non-compliant (ex. "Appx5805-08" on page 2). CORRECTION: When referring to a range of appendix pages, both the first and last page of the range must be listed in their entirety. For the example, the correct reference would be "Appx5805-5808." Please ensure future appendix references are compliant. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [472763] [MJL] [Entered: 11/03/2017 10:06 AM] (0) |
| Nov 2, 2017 | 27 | BRIEF FILED for Appellants Hospira, Inc. and InnoPharma Inc. [26]. Number of Pages: 59. Service: 11/02/2017 by email. The paper copies of the brief should be received by the court on or before 11/13/2017. Cross-Appellant Cephalon Inc.'s brief is due 12/12/2017. [472758] [MJL] [Entered: 11/03/2017 10:03 AM] (212) |
| Nov 2, 2017 | 26 | TENDERED from Appellants Hospira, Inc. and InnoPharma Inc.. Title: OPENING BRIEF. Service: 11/02/2017 by email. [472672] [Bradford Lyerla] [Entered: 11/02/2017 08:17 PM] (212) |
| Sep 14, 2017 | 25 | Entry of appearance for Joshua M. Segal as of counsel for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 09/14/2017 by email. [461051] [Joshua Segal] [Entered: 09/14/2017 03:30 PM] (2) |
| Sep 13, 2017 | 24 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The motion [22] filed by Appellants did not include a certificate of compliance. CORRECTION: Pursuant to FRAP 32(g)(1), motions must contain a certificate of compliance with the word count. Please ensure future motions include the certificate of compliance. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [460641] [MJL] [Entered: 09/13/2017 11:57 AM] (0) |
| Sep 13, 2017 | 23 | **TEXT ONLY** ORDER granting motion to extend time to file appellants' opening brief [22] filed by Appellants Hospira, Inc. and InnoPharma Inc. The brief is due 11/02/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [460639] [MJL] [Entered: 09/13/2017 11:55 AM] (0) |
| Sep 13, 2017 | 22 | MOTION of Appellants Hospira, Inc. and InnoPharma Inc. to extend the time to 11/02/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 09/13/2017 by email. [460633] [Bradford Lyerla] [Entered: 09/13/2017 11:42 AM] (7) |
| Sep 6, 2017 | 21 | Official caption revised to reflect party non-participation. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [458995] [MJL] [Entered: 09/06/2017 02:46 PM] (0) |
| Aug 30, 2017 | 20 | Second notice to counsel for Appellees Apotex Corp. and Apotex Inc.: The record of this case indicates that no Entry of Appearance, Certificate of Interest, or Docketing Statement has been filed. Please file these documents promptly. Service as of this date by Clerk of Court. [457763] [MJL] [Entered: 08/30/2017 01:52 PM] (0) |
| Aug 23, 2017 | 19 | Notice to counsel for Appellees Apotex Corp. and Apotex Inc.: The record of this case indicates that no Entry of Appearance, Certificate of Interest, or Docketing Statement has been filed. Please file these documents promptly. Service as of this date by Clerk of Court. [455984] [MJL] [Entered: 08/23/2017 08:46 AM] (0) |
| Aug 16, 2017 | 18 | Certificate of Interest for the Cross-Appellant Cephalon Inc.. Service: 08/16/2017 by email. [454502] [William Jay] [Entered: 08/16/2017 03:33 PM] (2) |
| Aug 16, 2017 | 17 | Docketing Statement for the Cross-Appellant Cephalon Inc.. Service: 08/16/2017 by email. [454493] [William Jay] [Entered: 08/16/2017 03:28 PM] (3) |
| Aug 16, 2017 | 16 | Notice of intent to file corresponding briefs on CD-ROM for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/16/2017 by email. [454413] [Bradford Lyerla] [Entered: 08/16/2017 01:36 PM] (3) |
| Aug 16, 2017 | 15 | Entry of appearance for Yusuf Esat as of counsel for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/16/2017 by email. [454411] [Bradford Lyerla] [Entered: 08/16/2017 01:34 PM] (2) |
| Aug 16, 2017 | 14 | Entry of appearance for Sara Tonnies Horton as of counsel for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/16/2017 by email. [454408] [Bradford Lyerla] [Entered: 08/16/2017 01:31 PM] (2) |
| Aug 16, 2017 | 13 | Entry of appearance for Bradford P. Lyerla as principal counsel for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/16/2017 by email. [454405] [Bradford Lyerla] [Entered: 08/16/2017 01:28 PM] (2) |
| Aug 16, 2017 | 12 | Corrected Certificate of Interest for the Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/16/2017 by email. [454403] [Bradford Lyerla] [Entered: 08/16/2017 01:24 PM] (2) |
| Aug 16, 2017 | 11 | Corrected Docketing Statement for the Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/16/2017 by email. [454398] [Bradford Lyerla] [Entered: 08/16/2017 01:22 PM] (4) |
| Aug 16, 2017 | 10 | Certificate of Interest for the Appellant Hospira, Inc.. Service: 08/16/2017 by email. [454384] [Bradford Lyerla] [Entered: 08/16/2017 01:10 PM] (2) |
| Aug 16, 2017 | 9 | Docketing Statement for the Appellant Hospira, Inc.. Service: 08/16/2017 by email. [454381] [Bradford Lyerla] [Entered: 08/16/2017 01:07 PM] (4) |
| Aug 16, 2017 | 8 | Entry of appearance for Calvin E. Wingfield as of counsel for Cross-Appellant Cephalon Inc.. Service: 08/16/2017 by email. [454317] [Calvin Wingfield] [Entered: 08/16/2017 11:05 AM] (2) |
| Aug 16, 2017 | 7 | Entry of appearance for Daryl L. Wiesen as of counsel for Cross-Appellant Cephalon Inc.. Service: 08/16/2017 by email. [454316] [Daryl Wiesen] [Entered: 08/16/2017 11:03 AM] (2) |
| Aug 16, 2017 | 6 | Entry of appearance for David J. Zimmer as of counsel for Cross-Appellant Cephalon Inc.. Service: 08/16/2017 by email. [454314] [David Zimmer] [Entered: 08/16/2017 10:59 AM] (2) |
| Aug 16, 2017 | 5 | Entry of appearance for Emily L. Rapalino as of counsel for Cross-Appellant Cephalon Inc.. Service: 08/16/2017 by email. [454310] [Emily Rapalino] [Entered: 08/16/2017 10:56 AM] (2) |
| Aug 16, 2017 | 4 | Entry of appearance for Nicholas K. Mitrokostas as of counsel for Cross-Appellant Cephalon Inc.. Service: 08/16/2017 by email. [454304] [William Jay] [Entered: 08/16/2017 10:52 AM] (2) |
| Aug 16, 2017 | 3 | Entry of appearance for William M. Jay as principal counsel for Cross-Appellant Cephalon Inc.. Service: 08/16/2017 by email. [454299] [William Jay] [Entered: 08/16/2017 10:48 AM] (2) |
| Aug 2, 2017 | 2 | Note to file: The following cases are consolidated: 17-2377 (Lead) with 17-2378 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [451023] [17-2377, 17-2378] [MJL] [Entered: 08/02/2017 04:10 PM] (0) |
| Aug 2, 2017 | 1 | Appeal docketed. Received: 07/31/2017. [451016]Entry of Appearance due 08/16/2017. Certificate of Interest due 08/16/2017. Docketing Statement due 08/16/2017. Appellant's brief is due 10/02/2017. [MJL] [Entered: 08/02/2017 03:51 PM] (111) |
